Plain-English translation of NCT07380698 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This trial is testing indocyanine green (ICG), a special fluorescent dye that helps surgeons see and remove lymph nodes during cancer surgery. The study will compare different doses and storage conditions of this dye to figure out which approach works best while keeping costs down. The goal is to help doctors treat endometrial, cervical, and vulvar cancers more effectively and precisely.
Surgeons currently use this medication to find sentinel lymph nodes—the first lymph nodes where cancer might spread—but doctors aren't sure which dose and storage method gives the best results at the lowest cost. This trial will answer those practical questions so every patient can benefit from the safest, most effective, and most affordable approach.
You likely qualify if…
You likely don't qualify if…
If you join this trial, you would receive the surgical dye indocyanine green as part of your planned cancer surgery—this is not an extra procedure, but rather part of your regular operation. Doctors will use the dye to help identify and remove the sentinel lymph nodes during your surgery. Your medical information (age, weight, cancer details, and surgical results) will be collected to help researchers understand which dose and storage method works best.
AI-generated summary from trial data · Jun 4, 2026 · Not medical advice
Turkey (Türkiye)
Sponsor
Cukurova University
Enrollment target
~30 participants
Started
October 2025
Primary completion
August 2026
Sex
Female only
Last updated on clinicaltrials.gov in February 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Ghanim Khatib, MD
Cukurova University
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.